Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NR2E1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AGER - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728716 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RNF41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
AGPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ISG20L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-DPB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM160B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMC5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDHD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DET1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM258 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STMN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01006 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on